| RESEARCH ARTICLE
|Year : 2011 | Volume
| Issue : 4 | Page : 389-392
Effect of imatinib on the biochemical parameters of the reproductive function in male Swiss albino mice
AM Prasad1, K Ramnarayan2, K Nalini3, KL Bairy4
1 Department of Anatomy, Melaka Manipal Medical College, Manipal, Karnataka, India
2 Department of Pathology, Melaka Manipal Medical College, Manipal, Karnataka, India
3 Department of Biochemistry, Kasturba Medical College, Manipal University, Manipal, Karnataka, India
4 Department of Pharmacology, Kasturba Medical College, Manipal University, Manipal, Karnataka, India
Background: Treatment of cancers with cytotoxic agents such as tyrosine kinase inhibiting drugs often, but not always, result in transient to permanent testicular dysfunction. Germ cells are important targets of many chemicals. Most of the drugs are genotoxins and induce irreversible effect on genetic makeup. These mutagenic changes are proportionally related to carcinogenesis. This is alarmingly dangerous in youth and children, since these effects last longer, affecting fertility or forming basis for carcinogenesis. There is paucity of reports on planned studies of imatinib on the testicular function. Hence, the study was planned to assess the effects of imatinib on biochemical markers of testicular functions in male Swiss albino mice.
Materials and Methods: Male Swiss albino mice were treated with imatinib and sacrificed at the end of first, second, fourth, fifth, seventh, and tenth week after the last exposure to imatinib. The testis were removed, weighed, and processed for biochemical analysis.
Results: The intratesticular testosterone level was significantly (P<0.001) reduced in treated groups and severe effect was observed on week 4 and 5. The intratesticular lactate dehydrogenase (LDH) level was significantly increased by imatinib in all treated groups up to week 5.
Conclusion: Imatinib does affect testosterone and LDH level significantly, but this effect is reversible once the drug is withdrawn. This finding may help the clinicians to plan and address the fertility-related issues in young patients of reproductive age who are being treated with imatinib for gastrointestinal tumors and chronic myeloid leukemia.
K L Bairy
Department of Pharmacology, Kasturba Medical College, Manipal University, Manipal, Karnataka
Source of Support: None, Conflict of Interest: None
[FULL TEXT] [PDF]*